![Oscar Groet](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oscar Groet
Directeur Général chez K.D. Pharma Bexbach GmbH
Postes actifs de Oscar Groet
Sociétés | Poste | Début | Fin |
---|---|---|---|
K.D. Pharma Bexbach GmbH
![]() K.D. Pharma Bexbach GmbH Pharmaceuticals: MajorHealth Technology K.D. Pharma Bexbach GmbH designs and develops technologies for the extraction and purification of fatty acids. It also supplies custom Omega-3 formulations to clients in the pharmaceutical industry. The firm's products are available as ethyl esters, free fatty acids, and triglycerides. The company was founded by Rudolf Krumbholz and Michael Dorscheid in 1988 and is headquartered in Bexbach, Germany. | Directeur Général | 01/05/2013 | - |
Sancilio & Co., Inc.
![]() Sancilio & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio & Co., Inc. operates as specialty pharmaceutical company. It develops and markets based products including those based on the proprietary Advanced Lipid Technologies platform. The company was founded by Frederick D. Sancilio in 2005 and is headquartered in Riviera Beach, FL. | Directeur/Membre du Conseil | - | - |
O³ Holding GmbH
![]() O³ Holding GmbH Financial ConglomeratesFinance O³ Holding GmbH is an investment holding private company based in Bexbach, Germany. The German company functions as an investment holding company. The CEO of the company is Oscar Groet. | Directeur Général | - | - |
KD Pharma Group SA
![]() KD Pharma Group SA Pharmaceuticals: MajorHealth Technology KD Pharma Group SA is a contract manufacturer specializing in the development of pharmaceutical and nutraceutical products. The private company is based in Bioggio, Switzerland, and has subsidiaries in Austria. The Swiss company is also one of the world's largest producers of omega-3 fatty acids, with a presence in several countries and employing over 500 people. KD Pharma Group uses state-of-the-art technology protected by numerous patents, and its quality assurance adheres to the pharmacopoeia, the European pharmacopoeia, or the group GMP purity parameters in its omega-3 fatty acids. The company was founded in 1981, and the CEO is Oscar Groet. | Directeur Général | - | - |
Historique de carrière de Oscar Groet
Anciens postes connus de Oscar Groet
Sociétés | Poste | Début | Fin |
---|---|---|---|
SAIC Iveco Commercial Vehicle Investment Co., Ltd.
![]() SAIC Iveco Commercial Vehicle Investment Co., Ltd. Financial ConglomeratesFinance SAIC Iveco Commercial Vehicle Investment Co., Ltd. functions as an investment holding Chinese company. The joint venture company is based in Shanghai, China. and has subsidiaries in China. | Directeur/Membre du Conseil | - | - |
Sancilio Pharmaceuticals Co., Inc.
![]() Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Directeur/Membre du Conseil | - | - |
Statistiques
Internationale
Allemagne | 3 |
Etats-Unis | 3 |
Chine | 2 |
Opérationnelle
Chief Executive Officer | 3 |
Director/Board Member | 3 |
Sectorielle
Health Technology | 3 |
Commercial Services | 3 |
Finance | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 6 |
---|---|
K.D. Pharma Bexbach GmbH
![]() K.D. Pharma Bexbach GmbH Pharmaceuticals: MajorHealth Technology K.D. Pharma Bexbach GmbH designs and develops technologies for the extraction and purification of fatty acids. It also supplies custom Omega-3 formulations to clients in the pharmaceutical industry. The firm's products are available as ethyl esters, free fatty acids, and triglycerides. The company was founded by Rudolf Krumbholz and Michael Dorscheid in 1988 and is headquartered in Bexbach, Germany. | Health Technology |
Sancilio & Co., Inc.
![]() Sancilio & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio & Co., Inc. operates as specialty pharmaceutical company. It develops and markets based products including those based on the proprietary Advanced Lipid Technologies platform. The company was founded by Frederick D. Sancilio in 2005 and is headquartered in Riviera Beach, FL. | Commercial Services |
Sancilio Pharmaceuticals Co., Inc.
![]() Sancilio Pharmaceuticals Co., Inc. Miscellaneous Commercial ServicesCommercial Services Sancilio Pharmaceuticals Co. engaged in the development and manufacture of pharmaceutical products. Its product platform, advanced lipid technologies, focuses on the treatment of diseases and disorders related to lipids such as sickle cell, short bowel, severe hypertriglyceridemia and non-alcoholic fatty liver. The company was founded by Frederick Sancilio in October 2004 and was headquartered in Riviera Beach, FL. | Commercial Services |
O³ Holding GmbH
![]() O³ Holding GmbH Financial ConglomeratesFinance O³ Holding GmbH is an investment holding private company based in Bexbach, Germany. The German company functions as an investment holding company. The CEO of the company is Oscar Groet. | Finance |
SAIC Iveco Commercial Vehicle Investment Co., Ltd.
![]() SAIC Iveco Commercial Vehicle Investment Co., Ltd. Financial ConglomeratesFinance SAIC Iveco Commercial Vehicle Investment Co., Ltd. functions as an investment holding Chinese company. The joint venture company is based in Shanghai, China. and has subsidiaries in China. | Finance |
KD Pharma Group SA
![]() KD Pharma Group SA Pharmaceuticals: MajorHealth Technology KD Pharma Group SA is a contract manufacturer specializing in the development of pharmaceutical and nutraceutical products. The private company is based in Bioggio, Switzerland, and has subsidiaries in Austria. The Swiss company is also one of the world's largest producers of omega-3 fatty acids, with a presence in several countries and employing over 500 people. KD Pharma Group uses state-of-the-art technology protected by numerous patents, and its quality assurance adheres to the pharmacopoeia, the European pharmacopoeia, or the group GMP purity parameters in its omega-3 fatty acids. The company was founded in 1981, and the CEO is Oscar Groet. | Health Technology |
- Bourse
- Insiders
- Oscar Groet
- Expérience